Category - Hot Stocks

Opening Recap Market Pulse: Heavyweights flexed their muscle again yesterday, sending the headline index hovering near 26K even as most portfolios drifted sideways or slipped into the red. Key Movers: Tata Consultancy Services...

Context and JPMorgan’s Revised Outlook JPMorgan has refreshed its view on Hormel Foods (NYSE: HRL) following the company’s latest earnings and guidance. Analyst Thomas Palmer maintains an Overweight rating and recently raised the...

This Morning's Snapshot Market Pulse: AI-driven crypto speculation and biotech restructuring tugged at sentiment overnight, sending risk assets on a roller-coaster while traditional sectors stayed on the sidelines. Key Movers:...

Company Overview and Pipeline CG Oncology, Inc. (NASDAQ: CGON) is a clinical-stage biopharmaceutical company specializing in bladder cancer therapies. Its lead product is cretostimogene (also known as CG0070), an oncolytic...

Opening Recap Market Pulse: Yesterday’s frenzy saw Moore Threads rip 420% in its debut, while AI valuations drew bubble warnings and housing prices hit fresh highs. Key Movers: Moore Threads’ blockbuster IPO (Forbes), Goldman...

Company Overview: Xenon Pharmaceuticals (NASDAQ: XENE) is a neuroscience-focused biopharmaceutical company specializing in ion-channel modulators for neurological disorders ([1]). Its lead candidate, azetukalner (XEN1101), is a...

Daily Financial Update Your no-BS morning rundown on markets, deals, climate risk, and fiscal policy Market Pulse: Indian equities drift as FIIs book gains and domestic funds hold fire, setting a consolidation tone through...

Introduction Stride, Inc. (NYSE: LRN) – an online education company formerly known as K12 Inc. – is facing a shareholder class action lawsuit amid a sharp stock price decline. The lawsuit (lead plaintiff deadline January 12...

Market Pulse: Tech and financial shares clawed back after a mixed session, but relentless foreign outflows and a wave of new listings have sapped breadth across most sectors. Key Movers: Meesho’s retail tranche booked out on Day...

Company Overview Ventyx Biosciences (NASDAQ: VTYX) is a clinical-stage biopharmaceutical company focused on developing novel oral therapies for inflammatory and autoimmune diseases ([1]). The company, headquartered in California...